Witherspoon Charles's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed May 31, 2023
- Accession no.
- 0001562180-23-004627
- Filed
- May 31, 2023
- Trade date
- May 30, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $343.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Witherspoon CharlesCIK 0001731739 | Officer (VP & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2023 | Common Stock | MOption exerciseAcquired | +1,000 | $102.51 | +$102,510 | 2,829.5 | Direct | |
| May 30, 2023 | Common Stock | SSaleDisposed | −1,000 | $343.05 | −$343,050 | 1,829.5 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2023 | Common Stock | MOption exerciseDisposed | −1,000 | $0.00 | $0 | 1,548 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.